Y-Intercept (HK)’s Prelude Therapeutics PRLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$38.7K Buy
+47,788
New +$38.7K ﹤0.01% 1569
2024
Q3
Sell
-18,839
Closed -$71.8K 1706
2024
Q2
$71.8K Buy
+18,839
New +$71.8K ﹤0.01% 1283